View Author
Fallah Arani, S
( Fallah Arani)
patient methotrexate fumarate group methotrexate group fumarate group psoriasis treatment therapy 12 weeks study event ef ficacy 27 patients plaque psoriasis baseline randomized fallah arani psoriasis vulgaris trial 4 weeks difference baseline pasi fumaric acid esters value plaque 25 patients 16 weeks ficacy fallah 26 patients british liver enzymes arani dermatologist fumarate therapy 15 mg laboratory severity index 855–861 author reduction vulgari association randomization 18æ1 ± 7æ0 6æ7 ± 4æ5 screening visit liver ciclosporin psoriasis area 14æ5 ± 3æ0 change 10æ5 ± 6æ7 ó 2011 safety result october 2006 week 4 level outpatient clinic dermatol ± sd pasi signi ficant differences severity medication quality point fumaric biological multicentre enzyme analysis 120 mg research nurse erasmus mc effectiveness dermatology endpoint outpatient
1 Most Recent Publications
|
Fumarates vs. methotrexate in moderate to severe chronic plaque psoriasis: a multicentre prospective randomized controlled clinical trial
(Article)
Fallah Arani, S Neumann, H.P. Hop, W.C.J. Thio, H.B. |
2011-04-01
|